METHOD FOR PREDICTION OF OUTCOME OF ACUTE DISEASE CAUSED BY NEW CORONAVIRUS INFECTION COVID-19
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to clinical and laboratory diagnostics, and can be used to predict the outcome of an acute disease caused by a novel coronavirus infection COVID-19 by blood plasma cytokine concentration. Prior to therapy, blood plasma concentrations of...
Saved in:
Main Authors | , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English Russian |
Published |
15.03.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to clinical and laboratory diagnostics, and can be used to predict the outcome of an acute disease caused by a novel coronavirus infection COVID-19 by blood plasma cytokine concentration. Prior to therapy, blood plasma concentrations of interleukin-6 (IL-6) and interleukin-18 (IL-18) are determined. At the first stage, the concentration of IL-18 is assessed, at the value of which is equal to or more than 81.6 pg/ml, a lethal outcome is predicted. If the value is less than 81.6 pg/ml, the second stage is carried out, at which the blood plasma concentration of IL-6 is evaluated, at the value of which is equal to or more than 23.5 pg/ml, a lethal outcome is predicted, less than 23.5 pg/ml - recovery is predicted.EFFECT: method enables expanding the range of agents used to predict the outcome of an acute disease caused by a novel coronavirus infection COVID-19, which allows to divide patients into two groups: recovered patients and patients with lethal outcome, due to determination of two cytokines in blood plasma before the beginning of therapy: IL-6 and IL-18.1 cl, 1 dwg, 3 ex
Изобретение относится к медицине, а именно к клинико-лабораторной диагностике, и может быть использовано для прогнозирования исхода острого заболевания, вызванного новой коронавирусной инфекцией COVID-19, по концентрации цитокинов в плазме крови. До начала терапии определяют в плазме крови концентрацию интерлейкина-6 (ИЛ-6) и интерлейкина-18 (ИЛ-18). На первой стадии оценивают концентрацию ИЛ-18, при значении которой равной или более 81,6 пг/мл прогнозируют летальный исход. При значении менее 81,6 пг/мл проводят вторую стадию, на которой оценивают в плазме крови концентрацию ИЛ-6, при значении которой равной или более 23,5 пг/мл прогнозируют летальный исход, менее 23,5 пг/мл - прогнозируют выздоровление. Способ обеспечивает возможность расширения арсенала средств, используемых для прогноза исхода острого заболевания, вызванного новой коронавирусной инфекцией COVID-19, которое позволяет разделить пациентов на две группы: выздоровевшие и пациенты с летальным исходом, за счет определения до начала терапии в плазме крови двух цитокинов: ИЛ-6 и ИЛ-18. 1 ил., 3 пр. |
---|---|
AbstractList | FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to clinical and laboratory diagnostics, and can be used to predict the outcome of an acute disease caused by a novel coronavirus infection COVID-19 by blood plasma cytokine concentration. Prior to therapy, blood plasma concentrations of interleukin-6 (IL-6) and interleukin-18 (IL-18) are determined. At the first stage, the concentration of IL-18 is assessed, at the value of which is equal to or more than 81.6 pg/ml, a lethal outcome is predicted. If the value is less than 81.6 pg/ml, the second stage is carried out, at which the blood plasma concentration of IL-6 is evaluated, at the value of which is equal to or more than 23.5 pg/ml, a lethal outcome is predicted, less than 23.5 pg/ml - recovery is predicted.EFFECT: method enables expanding the range of agents used to predict the outcome of an acute disease caused by a novel coronavirus infection COVID-19, which allows to divide patients into two groups: recovered patients and patients with lethal outcome, due to determination of two cytokines in blood plasma before the beginning of therapy: IL-6 and IL-18.1 cl, 1 dwg, 3 ex
Изобретение относится к медицине, а именно к клинико-лабораторной диагностике, и может быть использовано для прогнозирования исхода острого заболевания, вызванного новой коронавирусной инфекцией COVID-19, по концентрации цитокинов в плазме крови. До начала терапии определяют в плазме крови концентрацию интерлейкина-6 (ИЛ-6) и интерлейкина-18 (ИЛ-18). На первой стадии оценивают концентрацию ИЛ-18, при значении которой равной или более 81,6 пг/мл прогнозируют летальный исход. При значении менее 81,6 пг/мл проводят вторую стадию, на которой оценивают в плазме крови концентрацию ИЛ-6, при значении которой равной или более 23,5 пг/мл прогнозируют летальный исход, менее 23,5 пг/мл - прогнозируют выздоровление. Способ обеспечивает возможность расширения арсенала средств, используемых для прогноза исхода острого заболевания, вызванного новой коронавирусной инфекцией COVID-19, которое позволяет разделить пациентов на две группы: выздоровевшие и пациенты с летальным исходом, за счет определения до начала терапии в плазме крови двух цитокинов: ИЛ-6 и ИЛ-18. 1 ил., 3 пр. |
Author | Arsenteva Natalya Aleksandrovna Gavrilova Elena Gennadevna Korobova Zoya Romanovna Lyubimova Natalya Evgenevna Polushin Yurij Sergeevich Lebedeva Aleksandra Aleksandrovna Batsunov Oleg Konstantinovich Rubinshtejn Artem Arkadevich Totolyan Areg Artemovich Shlyk Irina Vladimirovna Stanevich Oksana Vladimirovna Vorobev Evgenij Aleksandrovich Kuznetsova Raisa Nikolaevna Kulikov Aleksandr Nikolaevich Vorobeva Snezhana Viktorovna |
Author_xml | – fullname: Shlyk Irina Vladimirovna – fullname: Kuznetsova Raisa Nikolaevna – fullname: Stanevich Oksana Vladimirovna – fullname: Rubinshtejn Artem Arkadevich – fullname: Vorobeva Snezhana Viktorovna – fullname: Arsenteva Natalya Aleksandrovna – fullname: Kulikov Aleksandr Nikolaevich – fullname: Batsunov Oleg Konstantinovich – fullname: Lebedeva Aleksandra Aleksandrovna – fullname: Korobova Zoya Romanovna – fullname: Vorobev Evgenij Aleksandrovich – fullname: Gavrilova Elena Gennadevna – fullname: Polushin Yurij Sergeevich – fullname: Lyubimova Natalya Evgenevna – fullname: Totolyan Areg Artemovich |
BookMark | eNqNizkOwjAQAF1AwfWH_UCKEJSI0qzXiot4kY8gGqIImQolkcL_hRA8gGqmmFmLxTAOaSVuDYWaFWh2cHakDAbDFlgDx4Dc0EclxkCgjCfpCVBGTwpOV7B0AWTHVrbGRQ_Gavr-yK1RWX7ciuWjf85p9-NGgKaAdZamsUvz1N_TkF6di_uqLItDhXnxR_IGzuY0CA |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences Physics |
DocumentTitleAlternate | Способ прогнозирования исхода острого заболевания, вызванного новой коронавирусной инфекцией COVID-19 |
ExternalDocumentID | RU2766347C1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_RU2766347C13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:20:18 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Russian |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_RU2766347C13 |
Notes | Application Number: RU20210122630 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220315&DB=EPODOC&CC=RU&NR=2766347C1 |
ParticipantIDs | epo_espacenet_RU2766347C1 |
PublicationCentury | 2000 |
PublicationDate | 20220315 |
PublicationDateYYYYMMDD | 2022-03-15 |
PublicationDate_xml | – month: 03 year: 2022 text: 20220315 day: 15 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | Federalnoe byudzhetnoe uchrezhdenie nauki "Sankt-Peterburgskij nauchno-issledovatelskij institut epidemiologii i mikrobiologii im. Pastera Federalnoj sluzhby po nadzoru v sfere zashchity prav potrebitelej i blagopoluchiya cheloveka" (FBUN NII epidemiologii i mikrobiologii imeni Pastera) |
RelatedCompanies_xml | – name: Federalnoe byudzhetnoe uchrezhdenie nauki "Sankt-Peterburgskij nauchno-issledovatelskij institut epidemiologii i mikrobiologii im. Pastera Federalnoj sluzhby po nadzoru v sfere zashchity prav potrebitelej i blagopoluchiya cheloveka" (FBUN NII epidemiologii i mikrobiologii imeni Pastera) |
Score | 3.37745 |
Snippet | FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to clinical and laboratory diagnostics, and can be used to predict the outcome of an acute... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING |
Title | METHOD FOR PREDICTION OF OUTCOME OF ACUTE DISEASE CAUSED BY NEW CORONAVIRUS INFECTION COVID-19 |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220315&DB=EPODOC&locale=&CC=RU&NR=2766347C1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV07b8IwED4h-txa2qr0JQ9VtqgEnKQZoirYjkilxCgPSpeivJBYAEFQ_37tFGiXdrNs-WSfdP589nd3AI9mahTm89RSDZxZKs5xrgqUy1Ws56WmZda0Y8pAYT8wBgl-HevjBsx2sTB1ntDPOjmisKhc2HtVn9fLn0csWnMr10_ZTHQtXtzYpsrWO-52ZdEChfZtNuSUE4UQO0yUILS7poBWbBLhKB3IW7RMs89GfRmUsvyNKO4ZHA6FsHl1Do3VpgUnZFd4rQXH_va_uwVHNUEzX4vOrRGuL-DDZ_GAUyT8NyQUSL2aB4K4i3gSE-4z2XRIEjNEvYg5EUPESSJGUf8dBewNER7ywBl5YRIhL3DZ93zCRx5VNesSkMtiMlDFkid79UzCZL-53hU054t5eQ0o7RXp1EoLgdcFxrqedopSSw1c5GlhYc1qQ_tPMTf_jN3CqdSzpGFp-h00q9WmvBe4XGUPtUa_AEVPioA |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8hfuFNUSN-9mB2W2TQbe6wmNF22ZStZGyIF8m-SLgAgRH_fbsJ6EVvTZu-tC95_fW1v_cewIMea5n-NDFkDSeGjFOcygLlUhmraa4oiTFp6WWgsOdrToRfRuqoBtNtLEyVJ_SzSo4oLCoV9l5U5_Xi5xGLVtzK1WMyFV3zZzs0qbTxjtvtsmiBRLsm63PKiUSIGUSSH5htXUAr1olwlPb1MjlveXMadsuglMVvRLFP4KAvhM2KU6gt1w2ok23htQYceZv_7gYcVgTNdCU6N0a4OoMPj4UOp0j4b0gokLoVDwRxG_EoJNxjZdMiUcgQdQfMGjBErGjAKOq-I5-9IcID7ltDN4gGyPVt9j2f8KFLZcU4B2SzkDiyWPJ4p55xEO0217mAvdl8ll8CijtZPDHiTOB1hrGqxq0sV2INZ2mcGVgxmtD8U8zVP2P3UHdCrzfuuf7rNRyXOi8pWYp6A3vFcp3fCowukrtKu1_owI1t |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=METHOD+FOR+PREDICTION+OF+OUTCOME+OF+ACUTE+DISEASE+CAUSED+BY+NEW+CORONAVIRUS+INFECTION+COVID-19&rft.inventor=Shlyk+Irina+Vladimirovna&rft.inventor=Kuznetsova+Raisa+Nikolaevna&rft.inventor=Stanevich+Oksana+Vladimirovna&rft.inventor=Rubinshtejn+Artem+Arkadevich&rft.inventor=Vorobeva+Snezhana+Viktorovna&rft.inventor=Arsenteva+Natalya+Aleksandrovna&rft.inventor=Kulikov+Aleksandr+Nikolaevich&rft.inventor=Batsunov+Oleg+Konstantinovich&rft.inventor=Lebedeva+Aleksandra+Aleksandrovna&rft.inventor=Korobova+Zoya+Romanovna&rft.inventor=Vorobev+Evgenij+Aleksandrovich&rft.inventor=Gavrilova+Elena+Gennadevna&rft.inventor=Polushin+Yurij+Sergeevich&rft.inventor=Lyubimova+Natalya+Evgenevna&rft.inventor=Totolyan+Areg+Artemovich&rft.date=2022-03-15&rft.externalDBID=C1&rft.externalDocID=RU2766347C1 |